Pharmacogenetic, clinical and demographic factors in the management of warfarin therapy
It has been estimated that, at any one time, more than one million people in the U.K. are taking the anticoagulant drug warfarin, for the treatment or prevention of venous thromboembolism. The incidence of life threatening haemorrhage, due to overdose, is approximately two per one hundred patient ye...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Sheffield Hallam University
2012
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.580610 |